Schizophrenia
MAPrc’s researchers are currently working on a number of projects investigating new treatment methods for people experiencing schizophrenia
The following projects are currently recruiting participants. Please contact us if you wish to receive
The Damian Project - The Use of Bazadoxifene as a Potential Treatment for Men with Schizophrenia
Thanks to the generous support of the Mohr family, and in honour of the memory of Damian Mohr, MAPrc is privileged to be able to conduct this exiciting new trial to explore the use of Bazadoxifene, a Selective Estrogen Receptor Modulator (SERM), as a potential treatment for men with Schizophrenia. FOR MORE DETAILS CLICK HERE
Adjunctive SERM Hormone Treatment for Men and Women with Schizophrenia and Schizoaffective Disorder
Men and women who are 18 and over, with schizophrenia or schizoaffective disorder, are invited to take part in a 12-week adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a medication that targets hormone receptors in the brain, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. For further details click here
National Register for Antipsychotics in Pregnancy (NRAMP)
EVestG (ElectrovestibuloGraphy)
We are currently trialling a new technique, EVestG (ElectrovestibuloGraphy) which is being investigated as a possible objective method for diagnosing participants with Schizophrenia. For further information click here or contact MAPrc on 9076 6564 or email maprc@monash.edu
.